Drug Stocks Mixed Today (Cell Therapeutics, Amylin Pharmaceuticals, PharmAthene)

Cell Therapeutics, Inc. (NASDAQ:CTIC) surged 1.84% to $0.382. Cell Therapeutics, Inc. develops, acquires and commercializes treatments for cancer. It focuses on building a biopharmaceutical company with a diversified portfolio of oncology drugs. Its research, development, acquisition and in-licensing activities concentrate on identifying and developing less toxic ways to treat cancer. Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) slid 0.12% to $12.68. The 52-week range of the stock is $9.51-$24.21. Amylin Pharmaceuticals, Inc. (Amylin) is a biopharmaceutical company engaged in discovery, development and commercialization of medicines. The Company is marketing two first-in-class medicines to treat diabetes, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection. PharmAthene, Inc. (AMEX:PIP) is up 2.82% to $3.65. The 52-week range of the stock is $1.13-$4.96. The stock is up more than 85% year-to-date. PharmAthene, Inc. is a biodefense company engaged in the development and commercialization of medical countermeasures against biological and chemical weapons.
tdp2664
Newsworthy Stocks